These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 1732321)
1. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. Smith EB; Breneman DL; Griffith RF; Hebert AA; Hickman JG; Maloney JM; Millikan LE; Sulica VI; Dromgoole SH; Sefton J J Am Acad Dermatol; 1992 Jan; 26(1):125-7. PubMed ID: 1732321 [No Abstract] [Full Text] [Related]
2. Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. Smith EB; Wiss K; Hanifin JM; Jordon RE; Rapini RP; Lasser AE; Kirschenbaum MB; Millikan LE; Parish LC; Rapaport MJ J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1116-7. PubMed ID: 2370340 [No Abstract] [Full Text] [Related]
3. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group. J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989 [TBL] [Abstract][Full Text] [Related]
4. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents. Alston SJ; Cohen BA; Braun M Pediatrics; 2003 Jan; 111(1):201-3. PubMed ID: 12509578 [TBL] [Abstract][Full Text] [Related]
5. Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream). Barkey WF J Am Acad Dermatol; 1987 Sep; 17(3):518-9. PubMed ID: 3655035 [No Abstract] [Full Text] [Related]
6. Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections. Rosen T; Elewski BE J Am Acad Dermatol; 1995 Jun; 32(6):1050-1. PubMed ID: 7751452 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309 [TBL] [Abstract][Full Text] [Related]
9. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Greenberg HL; Shwayder TA; Bieszk N; Fivenson DP Pediatr Dermatol; 2002; 19(1):78-81. PubMed ID: 11860579 [TBL] [Abstract][Full Text] [Related]
10. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826 [TBL] [Abstract][Full Text] [Related]
11. SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis. Katz HI; Bard J; Cole GW; Fischer S; McCormick GE; Medansky RS; Nesbitt LT; Rex IH Cutis; 1984 Aug; 34(2):183-8. PubMed ID: 6383734 [TBL] [Abstract][Full Text] [Related]
12. Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis. Barnetson RS; Marley J; Bullen M; Brookman S; Cowen P; Ellis D; Williams T Br J Dermatol; 1998 Oct; 139(4):675-8. PubMed ID: 9892913 [TBL] [Abstract][Full Text] [Related]
13. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis. Vlahovic TC J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Ablon G; Rosen T; Spedale J Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165 [No Abstract] [Full Text] [Related]
15. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis. Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784 [TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. Suschka S; Fladung B; Merk HF Mycoses; 2002 Apr; 45(3-4):91-6. PubMed ID: 12000508 [TBL] [Abstract][Full Text] [Related]
17. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis]. Zaun H; Luszpinski P Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169 [TBL] [Abstract][Full Text] [Related]
18. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis]. Klaschka F; Gartmann H; Weidinger G Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170 [TBL] [Abstract][Full Text] [Related]
19. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group. Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748 [TBL] [Abstract][Full Text] [Related]
20. A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canesten) 1% cream given for four weeks, in the treatment of tinea pedis. Evans EG Br J Dermatol; 1994 Apr; 130 Suppl 43():12-4. PubMed ID: 8186134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]